Breaking News

FDA stands by as the vaping industry flouts its orders; psilocybin shows promise for treating alcohol addiction

 

Daily Recap

The FDA stands by as the vaping industry flouts its orders

By Nicholas Florko and Elissa Welle

Hyacinth Empinado/STAT

A STAT investigation found that vape companies are regularly flouting the FDA's orders. And the agency is just letting it happen.

Read More

What Fauci's exit tells us about the ongoing fight against Covid

By Sarah Owermohle

Susan Walsh/AP

"We're not going to eliminate [Covid]," Fauci told STAT, reflecting on his decision to step down in December. "We're in a good place now."

Read More

STAT+: How a long-overlooked protein could remake neuroscience drug discovery — or plunge the FDA into controversy

By Jason Mast

Adobe

The study of neurofilament holds tremendous promise, some researchers say, but it is also at the center of controversy.

Read More

Psilocybin shows promise for treating alcohol addiction, new study finds

By Olivia Goldhill

Peter Dejong/AP

The research found that those given psilocybin-assisted therapy reduced heavy drinking by 83%, compared to 51% among those who got a placebo.

Read More

Opinion: The FDA is at a crossroads for reducing tobacco-related disease and death

By Michael B. Farber and Anand Shah

Jeff Chiu/AP

The Supreme Court's decision in West Virginia v. EPA could limit the FDA's efforts to regulate tobacco and e-cigarettes.

Read More

Opinion: To improve children's health in low-income countries, put pediatric surgery on par with preventing malaria or HIV

By Shiza Abbasi and Carrie B. Dolan

David Silverman/Getty Images

In low-income countries, where pediatric surgery is often nonexistent, investing in it saves and extends life and prevents disability.

Read More

Wednesday, August 24, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments